Skip to main content
 

HIV/HCV Co-Infections


Date: Apr 28, 2026 12:00 PM - 01:00 PM

Fee

$0.00

CE Hours

1.00

CE Units

0.100

Registration closes on May 12, 2026 01:00 AM

Activity Type

Knowledge

Target Audience(s)

Pharmacists

Accreditation(s)

Accreditation Council for Pharmacy Education
Accreditation Statement: Howard University College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

 

HIV/HCV Co-Infections
 

Objectives

  • Outline the difference in hallmark disease-state progression in HIV mono-infection, HCV mono-infection and HIV/HCV coinfection
  • Discuss the application of AASLD/IDSA guidance to evaluation, regimen selection, and monitoring for HCV therapy in people with HIV
  • Identify and manage high-yield drug-drug interactions (DAAs, ART, acid suppression, statins, and tenofovir exposure)
  • Describe the execution of a stepwise treatment plan for a complex patient, including post-SVR liver care and reinfection prevention.

Speaker(s)/Author(s)

Pierre Ndje, Pharm.D., BCPS

Activity Number

0010-9999-26-024-L02-P
Date: 04/28/26
Time: 12:00 PM - 01:00 PM

CE Hours

1.00